Latest Breaking News On - Agex therapeutics - Page 2 : comparemela.com

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJ milton harrisHudsonalpha institute of biotechnologyDrug administrationDunn crutcherEuropean unionBradley arant boult cummingsPfizer incNeuroderm ltdAgex therapeutics incAgex therapeuticsSerina therapeuticsBoard chairSteven ledgerInterim chief executiveHudsonalpha institute

AgeX Therapeutics, Inc : AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results

AgeX Therapeutics, Inc : AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesStefan klotterAgex therapeutics incSerina therapeutics incJuvenescence limited onTransition servicesSecurities exchangeExchange agreementDrug administrationSerina therapeuticsPreferred stockJuvenescence limitedSeriesb preferred stockSeparation agreementChief executive officerAccounting standards update

Head-To-Head Comparison: AgeX Therapeutics (NYSE:AGE) and NGM Biopharmaceuticals (NASDAQ:NGM)

NGM Biopharmaceuticals (NASDAQ:NGM – Get Free Report) and AgeX Therapeutics (NYSE:AGE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership. Volatility & Risk NGM Biopharmaceuticals has a […]

South san franciscoUnited statesMerck sharp dohme corpAgex therapeutics incBiopharmaceuticals incUniversity of california at irvineGet free reportAgex therapeuticsAgex therapeuticMerck sharpDohme corp

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc - AGE -February 27, 2024 at 03:20 pm EST

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of AgeX Therapeutics, Inc. with Serina Therapeutics,.

United statesLewiss kahnCharlesc foti jrKahn swick fotiAgex therapeutics incSerina therapeutics incFormer attorney generalLouisiana charlesKahn swickAgex therapeuticsSerina therapeuticsPartner lewisFormer louisiana attorney general

Xenetic Biosciences (NASDAQ:XBIO) versus AgeX Therapeutics (NYSE:AGE) Financial Survey

AgeX Therapeutics (NYSE:AGE – Get Free Report) and Xenetic Biosciences (NASDAQ:XBIO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends. Profitability This table compares AgeX Therapeutics and […]

United statesXenetic bioscienceXenetic biosciencesUniversity of california at irvineAgex therapeutics incXenetic biosciences incAgex therapeuticsGet free reportGiven xenetic bioscienceAgex therapeutics dailyNyse ageStock comparisonStock analysis